---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-112750"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:48:25.765276+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Sciences prices $6.5M registered direct and private placement

## Summary
- Gross proceeds ~$6.5M from sale of 20.3M shares (or pre-funded warrants) at $0.32 per share.
- Issues Series C and D warrants to purchase 20.3M shares each, both exercisable at $0.32 after stockholder approval.
- Series D exercise price resets to lower of $0.32 or lowest VWAP around a future reverse split, floor $0.0634.
- Amends existing Series A warrants to set floor price at $0.20 for price protection provisions.
- Net proceeds for therapeutic DNA production services development and general corporate purposes.

## SEC filing metadata
- accession: 0001104659-24-112750
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924112750/0001104659-24-112750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924112750/tm2427064d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-112750
- JSON: https://secwatch.observer/filing/0001104659-24-112750.json
- Plain text: https://secwatch.observer/filing/0001104659-24-112750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.